Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and oxaliplatin, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving chemotherapy before surgery may make the tumor smaller and reduce the amount
of normal tissue that needs to be removed. Giving chemotherapy after surgery may kill any
tumor cells that remain after surgery.
PURPOSE: This phase II trial is studying how well giving gemcitabine together with
oxaliplatin works in treating patients with pancreatic cancer that can be removed by surgery.